<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="brief-report">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2020.01881</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Perspective</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Single Nucleotide Polymorphism in <italic>KIR2DL1</italic> Is Associated With HLA-C Expression in Global Populations</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Vargas</surname> <given-names>Luciana de Brito</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/713647/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Dourado</surname> <given-names>Renata M.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/738880/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Amorim</surname> <given-names>Leonardo M.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/985658/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Ho</surname> <given-names>Brenda</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Calonga-Sol&#x000ED;s</surname> <given-names>Ver&#x000F3;nica</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/669156/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Issler</surname> <given-names>Hellen C.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/739193/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Marin</surname> <given-names>Wesley M.</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Beltrame</surname> <given-names>Marcia H.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/201712/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Petzl-Erler</surname> <given-names>Maria Luiza</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/89320/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Hollenbach</surname> <given-names>Jill A.</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/639339/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Augusto</surname> <given-names>Danillo G.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/160131/overview"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Programa de P&#x000F3;s-Gradua&#x000E7;&#x000E3;o em Gen&#x000E9;tica, Departamento de Gen&#x000E9;tica, Universidade Federal do Paran&#x000E1;</institution>, <addr-line>Curitiba</addr-line>, <country>Brazil</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco</institution>, <addr-line>San Francisco, CA</addr-line>, <country>United States</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Martin Maiers, National Marrow Donor Program, United States</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Julian Vivian, Monash University, Australia; Stephen K. Anderson, National Cancer Institute at Frederick, United States</p></fn>
<corresp id="c001">&#x0002A;Correspondence: Danillo G. Augusto <email>danillo&#x00040;augusto.bio.br</email></corresp>
<fn fn-type="other" id="fn001"><p>This article was submitted to NK and Innate Lymphoid Cell Biology, a section of the journal Frontiers in Immunology</p></fn></author-notes>
<pub-date pub-type="epub">
<day>21</day>
<month>08</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="collection">
<year>2020</year>
</pub-date>
<volume>11</volume>
<elocation-id>1881</elocation-id>
<history>
<date date-type="received">
<day>22</day>
<month>05</month>
<year>2020</year>
</date>
<date date-type="accepted">
<day>13</day>
<month>07</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2020 Vargas, Dourado, Amorim, Ho, Calonga-Sol&#x000ED;s, Issler, Marin, Beltrame, Petzl-Erler, Hollenbach and Augusto.</copyright-statement>
<copyright-year>2020</copyright-year>
<copyright-holder>Vargas, Dourado, Amorim, Ho, Calonga-Sol&#x000ED;s, Issler, Marin, Beltrame, Petzl-Erler, Hollenbach and Augusto</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract><p>Regulation of NK cell activity is mediated through killer-cell immunoglobulin-like receptors (KIR) ability to recognize human leukocyte antigen (HLA) class I molecules as ligands. Interaction of KIR and HLA is implicated in viral infections, autoimmunity, and reproduction and there is growing evidence of the coevolution of these two independently segregating gene families. By leveraging <italic>KIR</italic> and <italic>HLA-C</italic> data from 1000 Genomes consortium we observed that the <italic>KIR2DL1</italic> variant <italic>rs2304224</italic><sup>&#x0002A;</sup><italic>T</italic> is associated with lower expression of HLA-C in individuals carrying the ligand HLA-C2 (<italic>p</italic> = 0.0059). Using flow cytometry, we demonstrated that this variant is also associated with higher expression of KIR2DL1 on the NK cell surface (<italic>p</italic> = 0.0002). Next, we applied next generation sequencing to analyze <italic>KIR2DL1</italic> sequence variation in 109 Euro and 75 Japanese descendants. Analyzing the extended haplotype homozygosity, we show signals of positive selection for <italic>rs4806553</italic><sup>&#x0002A;</sup><italic>G</italic> and <italic>rs687000</italic><sup>&#x0002A;</sup><italic>G</italic>, which are in linkage disequilibrium with <italic>rs2304224</italic><sup>&#x0002A;</sup><italic>T</italic>. Our results suggest that lower expression of HLA-C2 ligands might be compensated for higher expression of the receptor KIR2DL1 and bring new insights into the coevolution of <italic>KIR</italic> and <italic>HLA</italic>.</p></abstract>
<kwd-group>
<kwd>NK cells</kwd>
<kwd>KIR</kwd>
<kwd>natural selection</kwd>
<kwd>linkage disequilibrium</kwd>
<kwd>coevolution</kwd>
<kwd>expression</kwd>
<kwd>population genetics</kwd>
</kwd-group>
<contract-sponsor id="cn001">Coordena&#x000E7;&#x000E3;o de Aperfei&#x000E7;oamento de Pessoal de N&#x000ED;vel Superior<named-content content-type="fundref-id">10.13039/501100002322</named-content></contract-sponsor>
<contract-sponsor id="cn002">Conselho Nacional de Desenvolvimento Cient&#x000ED;fico e Tecnol&#x000F3;gico<named-content content-type="fundref-id">10.13039/501100003593</named-content></contract-sponsor>
<contract-sponsor id="cn003">National Institutes of Health<named-content content-type="fundref-id">10.13039/100000002</named-content></contract-sponsor>
<counts>
<fig-count count="2"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="67"/>
<page-count count="8"/>
<word-count count="6231"/>
</counts>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<title>Introduction</title>
<p>The <italic>killer cell immunoglobulin-like receptor</italic> (KIR) genes on chromosome 19 encode receptors that interact with a subset of human leukocyte antigen (HLA) class I molecules, encoded by genes on chromosome 6, to regulate NK cell cytotoxicity against infected and neoplastic cells (<xref ref-type="bibr" rid="B1">1</xref>&#x02013;<xref ref-type="bibr" rid="B3">3</xref>). In fact, combinations of variants of <italic>KIR</italic> and <italic>HLA</italic> have been repeatedly associated with autoimmune disease (<xref ref-type="bibr" rid="B4">4</xref>&#x02013;<xref ref-type="bibr" rid="B6">6</xref>), cancer (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B8">8</xref>), viral infections (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B10">10</xref>), and are also implicated in reproduction (<xref ref-type="bibr" rid="B11">11</xref>&#x02013;<xref ref-type="bibr" rid="B14">14</xref>). As a result, the interaction of KIR and HLA is relevant to fitness and survival and candidate for evolutionary studies (<xref ref-type="bibr" rid="B15">15</xref>).</p>
<p>KIR recognize subsets of HLA-A (A3, A11, and Bw4), HLA-B (Bw4 and Bw6), and HLA-C (C1 and C2) molecules (<xref ref-type="bibr" rid="B16">16</xref>). <italic>HLA-C</italic> appears to have had a great impact on <italic>KIR</italic> evolution, driving the expansion of lineage III KIR, which are the receptor lineage that recognize HLA-C (<xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B18">18</xref>). The dimorphism in position 80 of HLA-C defines HLA-C1 (80<sup>Asn</sup>) and HLA-C2 (80<sup>Lys</sup>) and confers differential specificity to KIR. Among all ligands, the interaction between KIR2DL1 and HLA-C2 is responsible for the strongest regulatory signal and HLA-C seems to act as the main educator of NK cells (<xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B20">20</xref>).</p>
<p>Worldwide studies demonstrate coordinated frequencies of <italic>KIR</italic> and <italic>HLA</italic> in populations. In a comprehensive study consisting of 30 populations, Single et al. (<xref ref-type="bibr" rid="B21">21</xref>) found that increasing frequencies of activating KIR are correlated with decreased frequencies of their respective HLA ligands. On the other hand, Hollenbach et al. (<xref ref-type="bibr" rid="B22">22</xref>) showed positive correlation between the presence of KIR2DL3 and the presence of HLA-C1 in 105 worldwide populations. A strong and negative correlation of <italic>KIR</italic> gene-content haplotype <italic>A</italic> and HLA-C2, a pair which is associated with increased risk of pre-eclampsia, was found in eight populations from European, African, and Asian ancestries (<xref ref-type="bibr" rid="B11">11</xref>). Moreover, there is extensive evidence of balancing selection maintaining diversity in <italic>KIR</italic> genes (<xref ref-type="bibr" rid="B23">23</xref>&#x02013;<xref ref-type="bibr" rid="B25">25</xref>). <italic>KIR</italic> and <italic>HLA</italic> segregate independently and there are no reports of gametic association between these two gene families. Here, we show that a single nucleotide polymorphism (SNP) in <italic>KIR2DL1</italic> is associated with expression levels of the KIR2DL1 receptor on the cell surface and also with HLA-C expression.</p>
</sec>
<sec sec-type="results" id="s2">
<title>Results</title>
<sec>
<title><italic>KIR2DL1</italic> Variant <italic>rs2304224<sup>&#x0002A;</sup>T</italic> Is Associated With Lower Expression Levels of HLA-C</title>
<p>To search for possible signals of coevolution between <italic>KIR</italic> and <italic>HLA</italic>, we evaluated if variants in inhibitory KIR that bind to HLA-C could be associated with HLA-C expression levels in global populations. We leveraged the public sequencing information available for all populations in the 1000 Genomes Project (1KGP) (<xref ref-type="bibr" rid="B26">26</xref>) and retrieved the genotypic data available for SNPs located within <italic>KIR2DL1</italic> and <italic>KIR2DL23</italic> (<italic>rs2304224, rs11673144, rs12982263, rs34721508, rs35719984</italic>, and <italic>rs35861855</italic>) in 955 individuals of various ancestries. We also obtained <italic>HLA</italic> genotyping data available for those individuals (<xref ref-type="bibr" rid="B27">27</xref>).</p>
<p>Subsequently, we used previously published data of HLA-C expression levels (<xref ref-type="bibr" rid="B28">28</xref>) and imputed the expression for each <italic>HLA-C</italic> genotype in the 1KGP cohort. The variant <italic>rs2304224</italic><sup>&#x0002A;</sup><italic>T</italic> was associated with lower HLA-C expression levels in individuals <italic>HLA-C1/C2</italic> (<italic>p</italic> = 0.0420) and <italic>HLA-C2/C2</italic> (<italic>p</italic> = 0.0059), but not in <italic>HLA-C1/C1</italic> individuals (<italic>p</italic> = 0.0740; <xref ref-type="fig" rid="F1">Figure 1A</xref> and <xref ref-type="supplementary-material" rid="SM1">Supplementary Figure 1</xref>). This variant is in position 13 of exon 1 and causes a phenylalanine to valine change in the KIR2DL1 signal peptide. We replicated these results by imputing the HLA expression in an independent panel of 308 Brazilians Euro-descendants for which <italic>HLA</italic> genotyping data was available, and we sequenced the first exon of <italic>KIR2DL1</italic> to genotype <italic>rs2304224</italic> (<italic>p</italic> = 0.0107; <xref ref-type="fig" rid="F1">Figure 1B</xref>).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p>HLA-C and KIR2DL1 expression are associated with genetic variants. <bold>(A,B)</bold> <italic>rs2304224</italic> in <italic>KIR2DL1</italic> marks <italic>in silico</italic> HLA-C surface expression (<xref ref-type="bibr" rid="B28">28</xref>) in two different cohorts. The presence of allele <italic>rs2304224</italic>&#x0002A;<italic>T</italic> marks lower HLA-C expression in <bold>(A)</bold> 130 <italic>C2/C2</italic> homozygotes out of 955 individuals from 1000 genomes consortium and <bold>(B)</bold> 25 <italic>C2/C2</italic> homozygotes out of 308 Euro-Brazilians from Curitiba (present study). <bold>(C)</bold> Higher KIR2DL1 surface expression and <bold>(D)</bold> increased presence on NK cells are also associated with the variant <italic>rs2304224</italic>&#x0002A;<italic>T</italic> (<italic>p</italic> = 0.0002 and <italic>p</italic> = 0.0027, respectively). <bold>(E)</bold> <italic>HLA-C</italic> genotype is associated to KIR2DL1 surface expression (<italic>p</italic> = 0.0074). There is no difference in expression, however, between homozygotes <italic>C1/C1</italic> and heterozygotes <italic>C1/C2</italic> (<italic>p</italic> = 0.44). Homozygosity for <italic>C2/C2</italic>, on the other hand, is associated with lower KIR2DL1 surface expression than in <italic>C1/C1</italic> (<italic>p</italic> = 0.0031) and <italic>C1/C2</italic> (<italic>p</italic> = 0.0016). Each dot in the graphs represents one individual. Red dots indicate hemizygosity for <italic>KIR2DL1</italic>. Median values are shown in horizontal lines and statistical significance is indicated in the top right corners of each plot.</p></caption>
<graphic xlink:href="fimmu-11-01881-g0001.tif"/>
</fig>
<p>To demonstrate that our approach to impute the HLA-C expression is predictive of the cell surface expression <italic>in vivo</italic>, we measured the HLA-C surface levels of fresh CD3<sup>&#x0002B;</sup> cells in 30 individuals using flow cytometry and compared to the imputed values. We found a correlation of <italic>r</italic> = 0.62, <italic>p</italic> &#x0003C; 0.0001 (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure 2</xref>).</p>
</sec>
<sec>
<title><italic>rs2304224<sup>&#x0002A;</sup>T</italic> Is also Associated With Higher Surface Expression Levels of <italic>KIR2DL1</italic></title>
<p>We sought to investigate if the variant <italic>rs2304224</italic><sup>&#x0002A;</sup><italic>T</italic> in <italic>KIR2DL1</italic> was associated with KIR2DL1 surface expression. We used flow cytometry to quantify both the abundance of KIR2DL1 on the surface of NK cells (median fluorescence intensity, MFI) as well as the percentage of NK cells expressing KIR2DL1 on their surface (KIR2DL1<sup>&#x0002B;</sup> NK cell), and also interrogated if copy number variation of <italic>KIR2DL1</italic> affects surface expression. Although borderline, we did not find significant differences of expression levels in individuals carrying one copy (hemizygous) or two copies (homo- or heterozygous) of <italic>KIR2DL1</italic><sup>&#x0002B;</sup> (<italic>p</italic> = 0.0594; <xref ref-type="supplementary-material" rid="SM1">Supplementary Figure 3A</xref>). However, the number of KIR2DL1&#x0002B; NK cells was 2.16-fold higher in individuals carrying two copies (<italic>p</italic> = 0.0001; <xref ref-type="supplementary-material" rid="SM1">Supplementary Figure 3B</xref>). For all KIR2DL1 expression analyses, we used copy number of <italic>KIR2DL1</italic> as covariant in the regression model.</p>
<p>We observed that the allele <italic>rs2304224</italic><sup>&#x0002A;</sup><italic>T</italic>, associated with decreased HLA-C expression, was also associated with 1.54-fold increase of the KIR2DL1 surface expression (<italic>p</italic> = 0.0002) and a 1.41-fold increase of KIR2DL1<sup>&#x0002B;</sup> NK cells (<italic>p</italic> = 0.03; <xref ref-type="fig" rid="F1">Figures 1C,D</xref>). The median expression of each KIR allotype is shown in <xref ref-type="supplementary-material" rid="SM1">Supplementary Figure 4</xref>. We also observed that KIR2DL1 expression was decreased in individuals homozygous for the presence of the C2 ligand (<italic>C2/C2, p</italic> = 0.007; <xref ref-type="fig" rid="F1">Figure 1E</xref>).</p>
</sec>
<sec>
<title>Signals of Positive Selection for <italic>KIR2DL1</italic> Variants in Linkage Disequilibrium With <italic>rs2304224</italic></title>
<p>We next analyzed the entire <italic>KIR2DL1</italic> gene in a subset of 109 Euro-descendants and 75 Japanese descendants sequenced using our custom next generation sequencing method (<xref ref-type="bibr" rid="B29">29</xref>). In Euro descendants, we observed low correlation but strong linkage disequilibrium (LD) between <italic>rs2304224</italic> and three other variants (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figures 5A,B</xref>). The first variant is at position &#x02212;406 upstream of the <italic>KIR2DL1</italic> gene (<italic>rs4806553</italic>, D&#x02032; = 0.99, <italic>r</italic><sup>2</sup> = 0.18, <italic>p</italic> &#x0003C; 10<sup>&#x02212;8</sup>). The other variants are located within the coding region, in exon 4 (<italic>rs687000</italic>, D&#x02032; = 0.99, <italic>r</italic><sup>2</sup> = 0.52, <italic>p</italic> &#x0003C; 10<sup>&#x02212;12</sup>) and exon 7 (<italic>rs34721508</italic>, D&#x02032; = 0.99, <italic>r</italic><sup>2</sup> = 0.24, <italic>p</italic> &#x0003C; 10<sup>&#x02212;3</sup>). Weaker LD was observed for the same variants in Japanese descendants (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figures 5C,D</xref>). Frequencies for all SNPs in both populations are given in <xref ref-type="supplementary-material" rid="SM1">Supplementary Table 1</xref>. Moreover, the frequency of HLA-C2 in our Japanese-descendant cohort was 10.3% while in Euro-descendants it was 40.9%.</p>
<p>We searched for signals of population specific selection, for both Euro and Japanese descendants, by estimating the extended haplotype homozygosity (EHH) using <italic>rs2304224</italic> and also variants in significant LD with it as focal SNPs. The bifurcation patterns are consistent with positive selection increasing frequencies of the haplotype more rapidly than they could be broken by genetic recombination. Signals of positive selection were observed for the derived allele <italic>rs4806553</italic><sup>&#x0002A;</sup><italic>G</italic> in Japanese but not in Euro-descendants (<xref ref-type="fig" rid="F2">Figures 2A,C</xref>). Strong signals of positive selection were also observed for the derived allele <italic>rs687000</italic><sup>&#x0002A;</sup><italic>G</italic> in both Euro and Japanese descendants (<xref ref-type="fig" rid="F2">Figures 2B,D</xref>).</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption><p>Extended haplotype homozygosity (EHH) in <italic>KIR2DL1</italic>. The extended homozygosity analysis is based on the premise that advantageous alleles increase in frequency at a higher pace than the local recombination rate breaks down the haplotypes in which these alleles are located. Therefore, alleles marking regions with elevated extended homozygosity are possibly under recent positive selection. Here we identify extended haplotypes surrounding <italic>KIR2DL1</italic> variants <italic>rs4806553</italic> and <italic>rs687000</italic>. The possible haplotypes of <italic>rs4806553</italic> and <italic>rs687000</italic> in relation to <italic>rs2304224</italic> are represented at the top of the image. The continuous line represents the most common configuration between two variants, and the dashed line represent less frequent configurations. On the left of each haplotype, arrows indicate higher or lower expression of KIR2DL1 and HLA-C, as associated with <italic>rs2304224</italic> alleles <italic>G</italic> or <italic>T</italic>. A representation of the genomic organization of <italic>KIR2DL1</italic> with the indicated location of the three variants is represented above. <bold>(A)</bold> EHH graph of decay in homozygosity (left) and furcation plot (right) for <italic>rs4806553</italic> in Euro-Brazilians. The graph shows little to no difference between ancestral <italic>rs4806553</italic>&#x0002A;<italic>C</italic> (blue) and derived <italic>rs4806553</italic>&#x0002A;<italic>G</italic> (red) alleles in Euro-Brazilians. <bold>(C)</bold> EHH graph of decay in homozygosity (left) and furcation plot (right) for <italic>rs4806553</italic> in Japanese. In Japanese, elevated homozygosity is associated with derived allele <italic>rs4806553</italic>&#x0002A;<italic>G</italic> (red). <bold>(B)</bold> EHH graph of decay in homozygosity (left) and furcation plot (right) for <italic>rs687000</italic> in Brazilians with European ancestry and <bold>(D)</bold> Brazilians with Japanese ancestry. Elevated homozygosity associated with derived allele <italic>rs687000</italic>&#x0002A;<italic>G</italic> (red) is consistent with the selective sweep model, in which recent positive selection sweeps the diversity on nearby loci. Vertical dotted lines indicate the position of the core SNP. The thickness of each branch in the furcation plot is determined by haplotype frequency.</p></caption>
<graphic xlink:href="fimmu-11-01881-g0002.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="s3">
<title>Discussion</title>
<p>Previous results show that <italic>cis</italic> polymorphisms associated with <italic>HLA-C</italic> expression do not associate with NK cell activity (<xref ref-type="bibr" rid="B30">30</xref>), despite the compelling evidence that KIR-HLA are coevolving as an integrated system (<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B22">22</xref>). Here, we show evidence of coevolution of <italic>KIR</italic> and <italic>HLA</italic> by identifying a variant in <italic>KIR2DL1</italic> that was associated with surface expression of the ligand HLA-C2 in worldwide populations. The allele <italic>rs2304224</italic><sup>&#x0002A;</sup><italic>T</italic> was associated with lower expression of imputed HLA-C surface expression in 995 individuals from 1KGP and also in an independent cohort of 308 Brazilian Euro-descendants. The association was only observed in individuals carrying at least one copy of HLA-C2, which suggests an orchestrated and refined evolution between these two systems. Although the antibody used in this study (DT9) cross reacts with HLA-E, it has been demonstrated that its binding represents the surface expression of HLA-C (<xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B31">31</xref>) and also is correlated with mRNA expression levels of <italic>HLA-C</italic> measured by quantitative PCR (<xref ref-type="bibr" rid="B32">32</xref>). Therefore, our direct measurement of HLA-C expression in 30 individuals demonstrates that imputing HLA expression based on previously published data is predictive of the expression observed on the surface of fresh blood cells.</p>
<p>It is also interesting that the same allele <italic>rs2304224</italic><sup>&#x0002A;</sup><italic>T</italic> is associated with higher expression of the receptor KIR2DL1 in NK cells and also present in the high expressing <italic>KIR2DL1</italic><sup>&#x0002A;</sup><italic>002</italic>. The SNP <italic>rs2304224</italic> in exon 1 causes a non-synonymous substitution of valine (allele <italic>G</italic>) to phenylalanine (allele <italic>T</italic>) in the signal peptide. The hydrophobicity of the signal peptide can influence protein retention in the cytosol (<xref ref-type="bibr" rid="B33">33</xref>). According to the Wimley-White interfacial hydrophobicity scale (<xref ref-type="bibr" rid="B34">34</xref>), valine has a free energy of transfer of 0.07 &#x00394;G from water to bilayer, and the free energy of phenylalanine is &#x02212;1.13 &#x00394;G. The lower and negative value of phenylalanine indicates this transference is more favorable, and therefore, <italic>rs2304224</italic><sup>&#x0002A;</sup><italic>T</italic> may increase protein availability in the membrane. This could explain the increased KIR2DL1 expression associated with <italic>rs2304224</italic><sup>&#x0002A;</sup><italic>T</italic>.</p>
<p>The patterns that we observed for the expression of KIR2DL1 allotypes (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure 4</xref>) are consistent with previous studies (<xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B35">35</xref>&#x02013;<xref ref-type="bibr" rid="B37">37</xref>). Our results showing that copy number of <italic>KIR2DL1</italic> affects the quantity of KIR2DL1<sup>&#x0002B;</sup> NK cells corroborate those by B&#x000E9;ziat et al. (<xref ref-type="bibr" rid="B37">37</xref>). On the other hand, the lack of significant association that we observed between <italic>KIR2DL1</italic> copy number and the abundance of expression on the cell surface reinforces the idea that copy number does not affect levels of KIR2DL1 as strongly as it affects the proportion of cells expressing the receptor (<xref ref-type="bibr" rid="B37">37</xref>). The presence of HLA-C2 was associated with lower expression of surface KIR2DL1, according to our results and of others (<xref ref-type="bibr" rid="B35">35</xref>, <xref ref-type="bibr" rid="B38">38</xref>, <xref ref-type="bibr" rid="B39">39</xref>). However, differently from the observations from Le Luduec et al. (<xref ref-type="bibr" rid="B38">38</xref>), who observed that the expression of KIR2DL1 is associated to the presence of C2 in a dose dependent manner, we found association only in individuals carrying two copies of <italic>C2</italic>.</p>
<p>We found three SNPs in LD with <italic>rs2304224</italic> (D&#x02032; = 0.99, 0.18&#x02264; <italic>r</italic><sup>2</sup> &#x02264;0.51). The low correlation coefficient is explained by difference in the allele frequencies among them. The frequency of the variant <italic>rs2304224</italic><sup>&#x0002A;</sup><italic>T</italic> is 0.26 in Euro-Brazilians, while the frequency of <italic>rs4806553</italic><sup>&#x0002A;</sup><italic>C</italic> is 0.67; <italic>rs687000</italic><sup>&#x0002A;</sup><italic>A</italic> is 0.57; and <italic>rs34721508</italic><sup>&#x0002A;</sup><italic>C</italic> is 0.86. From the three variants in LD with <italic>rs2304224</italic>, only <italic>rs34721508</italic>, in exon 7, has been previously associated with differential expression levels of KIR2DL1 in transfected cell lines (<xref ref-type="bibr" rid="B36">36</xref>). That study showed that cells expressing allotypes with 245<sup>Cys</sup> have reduced protein stability and are more susceptible to ligand mediated expression down-regulation in comparison to those with 245<sup>Arg</sup>. Interestingly, this variant was also present in the 1KGP dataset, and we did not observe association of <italic>rs34721508</italic> genotypes with HLA-C imputed expression levels (<italic>p</italic> = 0.28). We also demonstrated that there is an additive effect of <italic>rs2304224</italic><sup>&#x0002A;</sup><italic>T</italic> and <italic>rs34721508</italic><sup>&#x0002A;</sup><italic>C</italic> on KIR2DL1 expression, which indicates that each has independent effect on the expression of KIR2DL1 (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure 6</xref>), despite the fact that both these variants are present in the high expressing <italic>KIR2DL1</italic><sup>&#x0002A;</sup><italic>002</italic> (<xref ref-type="supplementary-material" rid="SM1">Supplementary Table 1</xref>). This observation argues in favor of our approach to expand the analysis of individual SNPs rather than solely analyzing the common combinations of SNPs present in the most frequent <italic>KIR2DL1</italic> alleles.</p>
<p>We applied extended haplotype homozygosity (EHH) analysis to all SNPs in LD with <italic>rs2304224</italic>, using the next generation sequencing data that we generated for a subset of Euro and Japanese descendants. Homozygosity surrounding the derived allele <italic>rs4806553</italic><sup>&#x0002A;</sup><italic>G</italic> was prominent in the Japanese population, suggesting this allele has been under recent positive selection. Japanese populations are especially interesting because they exhibit the lowest frequency of the HLA-C2 allotype (only 8%) (<xref ref-type="bibr" rid="B40">40</xref>) and, accordingly, we report low frequency of C2 also in the Brazilians of Japanese ancestry (10.3%). The low frequency of HLA-C2 could be driving the evolution of <italic>KIR2DL1</italic> in the Japanese population.</p>
<p>The SNP <italic>rs4806553</italic> is located 406 kbp upstream of the <italic>KIR2DL1</italic> gene, in the sequence corresponding to its intermediate promoter (Pro-I), suggested to control protein expression in mature NK cells (<xref ref-type="bibr" rid="B41">41</xref>). Moreover, it has been shown that the Pro-I sequence containing allele <italic>rs4806553</italic><sup>&#x0002A;</sup><italic>C</italic> binds to the transcription factor activator protein-1 (AP1), while <italic>rs4806553</italic><sup>&#x0002A;</sup><italic>G</italic> abrogates this binding (<xref ref-type="bibr" rid="B42">42</xref>). This could potentially explain the higher expression of <italic>KIR2DL1</italic><sup>&#x0002A;</sup><italic>002</italic>, which contains allele <italic>rs4806553</italic><sup>&#x0002A;</sup><italic>C</italic>, in comparison to other <italic>KIR2DL1</italic> alleles carrying the variant <italic>rs4806553</italic><sup>&#x0002A;</sup><italic>G</italic>, such as <italic>KIR2DL1</italic><sup>&#x0002A;</sup><italic>004</italic> and <italic>KIR2DL1</italic><sup>&#x0002A;</sup><italic>006</italic> (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure 4</xref> and <xref ref-type="supplementary-material" rid="SM1">Supplementary Table 1</xref>). Our data suggests that the attenuation of NK inhibition mediated by KIR2DL1 represents an evolutionary advantage and is being favored by positive selection in the Japanese population.</p>
<p>Strong signals of positive selection were observed toward the derived allele <italic>rs687000</italic><sup>&#x0002A;</sup><italic>G</italic> in both our cohorts. This variant is a synonymous change in exon 4, without apparent impact on regulation of <italic>KIR2DL1</italic> expression. One hypothesis is that <italic>rs687000</italic><sup>&#x0002A;</sup><italic>G</italic> rose in frequency due to hitchhiking with a nearby variation that was positively selected and eventually fixed. We did not observe signals of positive selection for <italic>rs2304224</italic> and <italic>rs34721508</italic>, which strongly associate with KIR2DL1 expression levels. One possibility is that selection could be favoring specific <italic>KIR2DL1</italic> alleles that carry these variants. In fact, the combination of <italic>rs2304224</italic><sup>&#x0002A;</sup><italic>G</italic> (neutral), <italic>rs687000</italic><sup>&#x0002A;</sup><italic>G</italic> (positively selected), and <italic>rs34721508</italic><sup>&#x0002A;</sup><italic>C</italic> (neutral) defines <italic>KIR2DL1</italic><sup>&#x0002A;</sup><italic>003</italic>, the most frequent allele across all populations worldwide (<xref ref-type="bibr" rid="B43">43</xref>).</p>
<p>Coevolution of <italic>KIR</italic> and <italic>HLA</italic> is mostly driven by <italic>HLA-C</italic> (<xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B44">44</xref>), which encodes a strong educator for KIR<sup>&#x0002B;</sup> NK cells (<xref ref-type="bibr" rid="B45">45</xref>, <xref ref-type="bibr" rid="B46">46</xref>). A fine tuning mechanism of NK cell regulation through the cell-specific promoter NK-Pro (<xref ref-type="bibr" rid="B47">47</xref>) was recently proposed, in which expression levels of HLA-C during NK cell education combines with expression levels and interaction strength of KIR and HLA in mature NK cells to modulate their selectivity and cytotoxicity (<xref ref-type="bibr" rid="B48">48</xref>). KIR2DL1 is the receptor with the highest affinity and avidity to HLA-C, and mediates the strongest NK response (<xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B49">49</xref>). Therefore, it is plausible that variation in <italic>KIR2DL1</italic> could be under selection and also that <italic>KIR2DL1</italic> and <italic>HLA-C</italic> are coevolving. Here, we show a <italic>KIR2DL1</italic> variant that is associated with lower expression of KIR2DL1 and inversely associated with higher HLA-C expression in HLA-C2/C2 individuals. This could be an indication that higher levels of the ligand are being compensated by lower expression of the receptor. We also observed evidence of positive selection on KIR2DL1. Our data show that much remains to be understood regarding the mechanisms of the KIR-HLA recognition and evolution. They also bring insights into the evolution of these two systems and suggest that more questions will emerge as we explore more deeply <italic>KIR-HLA</italic> diversity at high resolution.</p>
</sec>
<sec sec-type="materials and methods" id="s4">
<title>Materials and Methods</title>
<sec>
<title>Samples</title>
<p>We analyzed a cohort of 308 individuals of predominantly European ancestry and 75 individuals of Japanese ancestry from Curitiba, Brazil. About 80% of the population from Curitiba self-reported as Euro-descendant (<xref ref-type="bibr" rid="B50">50</xref>), which is in accordance with previous genetic studies (<xref ref-type="bibr" rid="B51">51</xref>). For the Japanese descendants, we only included individuals who had two parents or four grandparents born in Japan, with no history of admixture with non-Japanese ancestries. In order to measure KIR2DL1 expression levels, we analyzed fresh blood cells from a subset of 48 Euro-descendants. A subset of 30 of these individuals were included in the HLA-C expression assay. Detailed information about the study design is given in <xref ref-type="supplementary-material" rid="SM1">Supplementary Figure 7</xref>. All individuals were living in Curitiba, Brazil, at the time of blood collection. Median age in the group was 26 years (ranging from 20 to 64) and the male/female ratio was 0.37.</p>
<p>For expression assays, we collected 8 mL of peripheral blood samples and isolated PBMC (peripheral blood mononuclear cells) using Leucosep<sup>TM</sup> tubes (Greiner Bio-One, Austria), which have a selective membrane for density-based lymphocyte separation, and Ficoll Hypaque (Sigma Aldrich, MO). Isolated PBMC were counted in a Neubauer chamber under an optical microscope. A total of 0.5 &#x000D7; 10<sup>6</sup> cells were incubated with specific antibodies for KIR2DL1 and HLA-C and analyzed by flow cytometry. Detailed description and gate strategy are shown in <xref ref-type="supplementary-material" rid="SM1">Supplementary Figure 8</xref>.</p>
</sec>
<sec>
<title><italic>KIR2DL1</italic> and <italic>HLA-C</italic> Genotyping</title>
<p>We initially sequenced exons 1, 4, 5, 7, and 9 to distinguish the main <italic>KIR2DL1</italic> allele groups using the Sanger method (<xref ref-type="bibr" rid="B52">52</xref>) in the 48 Euro-descendants included in the expression assay (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure 9</xref>). The sequences obtained were aligned with reference sequences from IPD-KIR database (<xref ref-type="bibr" rid="B43">43</xref>), using the software Mutation Surveyor&#x000AE; (SoftGenetics, PA) and identified manually. Additionally, we sequenced only the exon 1 (containing the variant <italic>rs2304224</italic>) in extra 260 Euro-descendant individuals to increase statistical power for the analysis of <italic>rs2304224</italic>.</p>
<p>We applied quantitative PCR to determine copy number of <italic>KIR2DL1</italic> compared to <italic>KIR3DL3</italic>, which is present in virtually all haplotypes. <italic>KIR2DL1</italic> was amplified in triplicate using one set of primers and the reference gene <italic>KIR3DL3</italic> was amplified using other three sets of primers, each in triplicate, in a total of 12 (4 &#x000D7; 3) reactions per sample. The sequence of all primers used for amplification, sequencing and copy number assay, including those designed in this study as well as those described previously (<xref ref-type="bibr" rid="B53">53</xref>&#x02013;<xref ref-type="bibr" rid="B57">57</xref>) are given in <xref ref-type="supplementary-material" rid="SM1">Supplementary Table 2</xref>.</p>
<p>We also sequenced the entire <italic>KIR2DL1</italic> gene in 109 Euro-descendants and 75 Japanese descendants from Curitiba, Brazil. These samples were sequenced using the previously published method for next generation sequencing of <italic>KIR</italic> and <italic>HLA</italic> genes (<xref ref-type="bibr" rid="B29">29</xref>) using Illumina platform.</p>
</sec>
<sec>
<title>Data Analysis</title>
<p>Normality of variables was tested using Kolmogorov-Smirnov test, in R package <italic>nortest</italic> (<xref ref-type="bibr" rid="B58">58</xref>). Difference in HLA-C expression between <italic>KIR2DL1</italic> SNP genotypes was tested via the Kruskal-Wallis test, using <italic>stats</italic> R (<xref ref-type="bibr" rid="B59">59</xref>). <italic>Post-hoc</italic> analysis of Dunn was applied to Kruskal-Wallis results in order to identify pair-wise significant differences between genotypes, in R package <italic>dunn.test</italic> (<xref ref-type="bibr" rid="B60">60</xref>). Median HLA-C expression by allele, as defined by Apps et al. (<xref ref-type="bibr" rid="B28">28</xref>), was imputed for each allele in an individual, and then summed. The imputation was performed in all 308 Brazilians of European ancestry sequenced for <italic>rs2304224</italic> and 1KGP individuals. Correlation analysis between expected HLA-C expression in CD3<sup>&#x0002B;</sup> cells and <italic>in vivo</italic> HLA-C expression in CD3<sup>&#x0002B;</sup> cells was calculated with R package <italic>Hmisc</italic> (<xref ref-type="bibr" rid="B61">61</xref>). Difference in KIR2DL1 expression according to copy number was tested using Mann-Whitney, in <italic>stats</italic> R (<xref ref-type="bibr" rid="B59">59</xref>). Association of KIR2DL1 expression with allotype and <italic>rs2304224</italic> was tested through logistic regression using copy number as a covariate, also in <italic>stats</italic> R. Linkage disequilibrium was estimated using LD function from R package <italic>genetics</italic> (<xref ref-type="bibr" rid="B62">62</xref>) and plotted with a modified version of R package <italic>LDheatmap</italic> (<xref ref-type="bibr" rid="B63">63</xref>). Median expression graphs were plotted using <italic>base</italic> and <italic>beeswarm</italic> R packages (<xref ref-type="bibr" rid="B59">59</xref>, <xref ref-type="bibr" rid="B64">64</xref>).</p>
<p><italic>KIR2DL1</italic> SNPs obtained from genomic sequence data were phased using fastPHASE, with modified parameters (-T10 -H200). The phased data was used for estimation of extended haplotype homozygosity (EHH) (<xref ref-type="bibr" rid="B65">65</xref>) using R package <italic>rehh</italic> (<xref ref-type="bibr" rid="B66">66</xref>). Ancestral and derived alleles were defined according to the Database of Single Nucleotide Polymorphisms (dbSNP) (<xref ref-type="bibr" rid="B67">67</xref>).</p>
</sec>
</sec>
<sec sec-type="data-availability-statement" id="s5">
<title>Data Availability Statement</title>
<p>All datasets generated for this study are included in the article/<xref ref-type="sec" rid="s9">Supplementary Material</xref>.</p>
</sec>
<sec id="s6">
<title>Ethics Statement</title>
<p>The studies involving human participants were reviewed and approved by Brazilian National Human Research Ethics Committee (CONEP), Protocol No. CAAE 02727412.4.0000.0096, in accordance to the Brazilian Federal laws. The patients/participants provided their written informed consent to participate in this study.</p>
</sec>
<sec id="s7">
<title>Author Contributions</title>
<p>DA designed the study. LV, RD, VC-S, LA, and HI performed Sanger sequencing and genotyping. LV, DA, and BH performed next generation sequencing. LV, RD, and DA performed flow cytometry analysis. LV, DA, and WM analyzed the data. MP-E, JH, and DA contributed with samples and/or reagents. LV and DA drafted the manuscript. All authors contributed to the article and approved the submitted version.</p>
</sec>
<sec id="s8">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<ack><p>We would like to thank all the volunteers who participated in this study and all the members of the Human Molecular Laboratory of the Federal University of Paran&#x000E1;, Brazil, for their unconditional support.</p>
</ack>
<sec sec-type="supplementary-material" id="s9">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fimmu.2020.01881/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fimmu.2020.01881/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Data_Sheet_1.pdf" id="SM1" mimetype="application/pdf" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kiessling</surname> <given-names>R</given-names></name> <name><surname>Klein</surname> <given-names>E</given-names></name> <name><surname>Pross</surname> <given-names>H</given-names></name> <name><surname>Wigzell</surname> <given-names>H</given-names></name></person-group>. <article-title>&#x0201C;Natural&#x0201D; killer cells in the mouse. II. Cytotoxic cells with specificity for mouse moloney leukemia cells. Characteristics of the killer cell</article-title>. <source>Eur J Immunol.</source> (<year>1975</year>) <volume>5</volume>:<fpage>117</fpage>&#x02013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1002/eji.1830050209</pub-id><pub-id pub-id-type="pmid">1086218</pub-id></citation></ref>
<ref id="B2">
<label>2.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Waggoner</surname> <given-names>SN</given-names></name> <name><surname>Reighard</surname> <given-names>SD</given-names></name> <name><surname>Gyurova</surname> <given-names>IE</given-names></name> <name><surname>Cranert</surname> <given-names>SA</given-names></name> <name><surname>Mahl</surname> <given-names>SE</given-names></name> <name><surname>Karmele</surname> <given-names>EP</given-names></name> <etal/></person-group>. <article-title>Roles of natural killer cells in antiviral immunity</article-title>. <source>Curr Opin Virol.</source> (<year>2016</year>) <volume>16</volume>:<fpage>15</fpage>&#x02013;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1016/j.coviro.2015.10.008</pub-id><pub-id pub-id-type="pmid">26590692</pub-id></citation></ref>
<ref id="B3">
<label>3.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ciccone</surname> <given-names>E</given-names></name> <name><surname>Pende</surname> <given-names>D</given-names></name> <name><surname>Viale</surname> <given-names>O</given-names></name> <name><surname>Di Donate</surname> <given-names>C</given-names></name> <name><surname>Tripodi</surname> <given-names>G</given-names></name> <name><surname>Orengo</surname> <given-names>AM</given-names></name> <etal/></person-group>. <article-title>Evidence of a natural killer (NK) cell repertoire for (allo) antigen recognition: definition of five distinct NK-determined allospecificities in humans</article-title>. <source>J Exp Med.</source> (<year>1992</year>) <volume>175</volume>:<fpage>709</fpage>&#x02013;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1084/jem.175.3.709</pub-id><pub-id pub-id-type="pmid">1371301</pub-id></citation></ref>
<ref id="B4">
<label>4.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>van der Slik</surname> <given-names>AR</given-names></name> <name><surname>Koeleman</surname> <given-names>BPC</given-names></name> <name><surname>Verduijn</surname> <given-names>W</given-names></name> <name><surname>Bruining</surname> <given-names>GJ</given-names></name> <name><surname>Roep</surname> <given-names>BO</given-names></name> <name><surname>Giphart</surname> <given-names>MJ</given-names></name></person-group>. <article-title>KIR in type 1 diabetes: disparate distribution of activating and inhibitory natural killer cell receptors in patients versus HLA-matched control subjects</article-title>. <source>Diabetes.</source> (<year>2003</year>) <volume>52</volume>:<fpage>2639</fpage>&#x02013;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.2337/diabetes.52.10.2639</pub-id><pub-id pub-id-type="pmid">14514651</pub-id></citation></ref>
<ref id="B5">
<label>5.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Augusto</surname> <given-names>DG</given-names></name> <name><surname>Lobo-Alves</surname> <given-names>SC</given-names></name> <name><surname>Melo</surname> <given-names>MF</given-names></name> <name><surname>Pereira</surname> <given-names>NF</given-names></name> <name><surname>Petzl-Erler</surname> <given-names>ML</given-names></name></person-group>. <article-title>Activating KIR and HLA Bw4 ligands are associated to decreased susceptibility to pemphigus foliaceus, an autoimmune blistering skin disease</article-title>. <source>PLoS ONE.</source> (<year>2012</year>) <volume>7</volume>:<fpage>e39991</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0039991</pub-id><pub-id pub-id-type="pmid">22768326</pub-id></citation></ref>
<ref id="B6">
<label>6.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname> <given-names>GW</given-names></name> <name><surname>Martin</surname> <given-names>MP</given-names></name> <name><surname>Gladman</surname> <given-names>D</given-names></name> <name><surname>Wade</surname> <given-names>J</given-names></name> <name><surname>Trowsdale</surname> <given-names>J</given-names></name> <name><surname>Carrington</surname> <given-names>M</given-names></name></person-group>. <article-title>Cutting edge: heterozygote advantage in autoimmune disease: hierarchy of protection/susceptibility conferred by HLA and killer Ig-like receptor combinations in psoriatic arthritis</article-title>. <source>J Immunol.</source> (<year>2004</year>) <volume>173</volume>:<fpage>4273</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.173.7.4273</pub-id><pub-id pub-id-type="pmid">15383555</pub-id></citation></ref>
<ref id="B7">
<label>7.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jobim</surname> <given-names>MR</given-names></name> <name><surname>Jobim</surname> <given-names>M</given-names></name> <name><surname>Salim</surname> <given-names>PH</given-names></name> <name><surname>Portela</surname> <given-names>P</given-names></name> <name><surname>Jobim</surname> <given-names>LF</given-names></name> <name><surname>Leistner-Segal</surname> <given-names>S</given-names></name> <etal/></person-group>. <article-title>Analysis of KIR gene frequencies and HLA class I genotypes in breast cancer and control group</article-title>. <source>Hum Immunol.</source> (<year>2013</year>) <volume>74</volume>:<fpage>1130</fpage>&#x02013;<lpage>3</lpage>. <pub-id pub-id-type="doi">10.1016/j.humimm.2013.06.021</pub-id></citation></ref>
<ref id="B8">
<label>8.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Middleton</surname> <given-names>D</given-names></name> <name><surname>Diler</surname> <given-names>AS</given-names></name> <name><surname>Meenagh</surname> <given-names>A</given-names></name> <name><surname>Sleator</surname> <given-names>C</given-names></name> <name><surname>Gourraud</surname> <given-names>PA</given-names></name></person-group>. <article-title>Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia</article-title>. <source>Tissue Antigens.</source> (<year>2009</year>) <volume>73</volume>:<fpage>553</fpage>&#x02013;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1111/j.1399-0039.2009.01235.x</pub-id><pub-id pub-id-type="pmid">19493232</pub-id></citation></ref>
<ref id="B9">
<label>9.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname> <given-names>MP</given-names></name> <name><surname>Qi</surname> <given-names>Y</given-names></name> <name><surname>Gao</surname> <given-names>X</given-names></name> <name><surname>Yamada</surname> <given-names>E</given-names></name> <name><surname>Martin</surname> <given-names>JN</given-names></name> <name><surname>Pereyra</surname> <given-names>F</given-names></name> <etal/></person-group>. <article-title>Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1</article-title>. <source>Nat Genet.</source> (<year>2007</year>) <volume>39</volume>:<fpage>733</fpage>&#x02013;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1038/ng2035</pub-id><pub-id pub-id-type="pmid">17496894</pub-id></citation></ref>
<ref id="B10">
<label>10.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Khakoo</surname> <given-names>SI</given-names></name> <name><surname>Thio</surname> <given-names>CL</given-names></name> <name><surname>Martin</surname> <given-names>MP</given-names></name> <name><surname>Brooks</surname> <given-names>CR</given-names></name> <name><surname>Gao</surname> <given-names>X</given-names></name> <name><surname>Astemborski</surname> <given-names>J</given-names></name> <etal/></person-group>. <article-title>HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection</article-title>. <source>Science.</source> (<year>2004</year>) <volume>305</volume>:<fpage>872</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1126/science.1097670</pub-id><pub-id pub-id-type="pmid">15297676</pub-id></citation></ref>
<ref id="B11">
<label>11.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hiby</surname> <given-names>SE</given-names></name> <name><surname>Walker</surname> <given-names>JJ</given-names></name> <name><surname>O&#x00027;Shaughnessy</surname> <given-names>KM</given-names></name> <name><surname>Redman</surname> <given-names>CWG</given-names></name> <name><surname>Carrington</surname> <given-names>M</given-names></name> <name><surname>Trowsdale</surname> <given-names>J</given-names></name> <etal/></person-group>. <article-title>Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success</article-title>. <source>J Exp Med.</source> (<year>2004</year>) <volume>200</volume>:<fpage>957</fpage>&#x02013;<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20041214</pub-id><pub-id pub-id-type="pmid">15477349</pub-id></citation></ref>
<ref id="B12">
<label>12.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Trowsdale</surname> <given-names>J</given-names></name> <name><surname>Moffett</surname> <given-names>A</given-names></name></person-group>. <article-title>NK receptor interactions with MHC class I molecules in pregnancy</article-title>. <source>Semin Immunol.</source> (<year>2008</year>) <volume>20</volume>:<fpage>317</fpage>&#x02013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1016/j.smim.2008.06.002</pub-id><pub-id pub-id-type="pmid">18656382</pub-id></citation></ref>
<ref id="B13">
<label>13.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nakimuli</surname> <given-names>A</given-names></name> <name><surname>Chazara</surname> <given-names>O</given-names></name> <name><surname>Hiby</surname> <given-names>SE</given-names></name> <name><surname>Farrell</surname> <given-names>L</given-names></name> <name><surname>Tukwasibwe</surname> <given-names>S</given-names></name> <name><surname>Jayaraman</surname> <given-names>J</given-names></name> <etal/></person-group>. <article-title>A KIR B centromeric region present in Africans but not Europeans protects pregnant women from pre-eclampsia</article-title>. <source>Proc Natl Acad Sci USA.</source> (<year>2015</year>) <volume>112</volume>:<fpage>845</fpage>&#x02013;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1413453112</pub-id><pub-id pub-id-type="pmid">25561558</pub-id></citation></ref>
<ref id="B14">
<label>14.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bulmer</surname> <given-names>JN</given-names></name> <name><surname>Lash</surname> <given-names>GE</given-names></name></person-group>. <article-title>The role of uterine NK cells in normal reproduction and reproductive disorders</article-title>. <source>Adv Exp Med Biol.</source> (<year>2015</year>) <volume>868</volume>:<fpage>95</fpage>&#x02013;<lpage>126</lpage>. <pub-id pub-id-type="doi">10.1007/978-3-319-18881-2_5</pub-id><pub-id pub-id-type="pmid">26178847</pub-id></citation></ref>
<ref id="B15">
<label>15.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Parham</surname> <given-names>P</given-names></name></person-group>. <article-title>MHC class I molecules and KIRS in human history, health and survival</article-title>. <source>Nat Rev Immunol.</source> (<year>2005</year>) <volume>5</volume>:<fpage>201</fpage>&#x02013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1038/nri1570</pub-id><pub-id pub-id-type="pmid">15719024</pub-id></citation></ref>
<ref id="B16">
<label>16.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Augusto</surname> <given-names>DG</given-names></name> <name><surname>Petzl-Erler</surname> <given-names>ML</given-names></name></person-group>. <article-title>KIR and HLA under pressure: evidences of coevolution across worldwide populations</article-title>. <source>Hum Genet.</source> (<year>2015</year>) <volume>134</volume>:<fpage>929</fpage>&#x02013;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1007/s00439-015-1579-9</pub-id><pub-id pub-id-type="pmid">26099314</pub-id></citation></ref>
<ref id="B17">
<label>17.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Older Aguilar</surname> <given-names>AM</given-names></name> <name><surname>Guethlein</surname> <given-names>LA</given-names></name> <name><surname>Adams</surname> <given-names>EJ</given-names></name> <name><surname>Abi-Rached</surname> <given-names>L</given-names></name> <name><surname>Moesta</surname> <given-names>AK</given-names></name> <name><surname>Parham</surname> <given-names>P</given-names></name></person-group>. <article-title>Coevolution of killer cell Ig-like receptors with HLA-C to become the major variable regulators of human NK cells</article-title>. <source>J Immunol.</source> (<year>2010</year>) <volume>185</volume>:<fpage>4238</fpage>&#x02013;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1001494</pub-id><pub-id pub-id-type="pmid">20805421</pub-id></citation></ref>
<ref id="B18">
<label>18.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Parham</surname> <given-names>P</given-names></name> <name><surname>Guethlein</surname> <given-names>LA</given-names></name></person-group>. <article-title>Genetics of natural killer cells in human health, disease, and survival</article-title>. <source>Annu Rev Immunol.</source> (<year>2018</year>) <volume>36</volume>:<fpage>519</fpage>&#x02013;<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-immunol-042617-053149</pub-id><pub-id pub-id-type="pmid">29394121</pub-id></citation></ref>
<ref id="B19">
<label>19.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stewart</surname> <given-names>CA</given-names></name> <name><surname>Laugier-Anfossi</surname> <given-names>F</given-names></name> <name><surname>Vely</surname> <given-names>F</given-names></name> <name><surname>Saulquin</surname> <given-names>X</given-names></name> <name><surname>Riedmuller</surname> <given-names>J</given-names></name> <name><surname>Tisserant</surname> <given-names>A</given-names></name> <etal/></person-group>. <article-title>Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors</article-title>. <source>Proc Natl Acad Sci USA.</source> (<year>2005</year>) <volume>102</volume>:<fpage>13224</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0503594102</pub-id><pub-id pub-id-type="pmid">16141329</pub-id></citation></ref>
<ref id="B20">
<label>20.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hilton</surname> <given-names>HG</given-names></name> <name><surname>Guethlein</surname> <given-names>LA</given-names></name> <name><surname>Goyos</surname> <given-names>A</given-names></name> <name><surname>Nemat-Gorgani</surname> <given-names>N</given-names></name> <name><surname>Bushnell</surname> <given-names>DA</given-names></name> <name><surname>Norman</surname> <given-names>PJ</given-names></name> <etal/></person-group>. <article-title>Polymorphic HLA-C receptors balance the functional characteristics of KIR haplotypes</article-title>. <source>J Immunol.</source> (<year>2015</year>) <volume>195</volume>:<fpage>3160</fpage>&#x02013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1501358</pub-id><pub-id pub-id-type="pmid">26311903</pub-id></citation></ref>
<ref id="B21">
<label>21.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Single</surname> <given-names>RM</given-names></name> <name><surname>Martin</surname> <given-names>MP</given-names></name> <name><surname>Gao</surname> <given-names>X</given-names></name> <name><surname>Meyer</surname> <given-names>D</given-names></name> <name><surname>Yeager</surname> <given-names>M</given-names></name> <name><surname>Kidd</surname> <given-names>JR</given-names></name> <etal/></person-group>. <article-title>Global diversity and evidence for coevolution of KIR and HLA</article-title>. <source>Nat Genet.</source> (<year>2007</year>) <volume>39</volume>:<fpage>1114</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1038/ng2077</pub-id><pub-id pub-id-type="pmid">17694058</pub-id></citation></ref>
<ref id="B22">
<label>22.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hollenbach</surname> <given-names>JA</given-names></name> <name><surname>Augusto</surname> <given-names>DG</given-names></name> <name><surname>Alaez</surname> <given-names>C</given-names></name> <name><surname>Bubnova</surname> <given-names>L</given-names></name> <name><surname>Fae</surname> <given-names>I</given-names></name> <name><surname>Fischer</surname> <given-names>G</given-names></name> <etal/></person-group>. <article-title>16th IHIW: population global distribution of killer immunoglobulin-like receptor (KIR) and ligands</article-title>. <source>Int J Immunogenet</source>. (<year>2013</year>) <volume>40</volume>:<fpage>39</fpage>&#x02013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1111/iji.12028</pub-id><pub-id pub-id-type="pmid">23280119</pub-id></citation></ref>
<ref id="B23">
<label>23.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Augusto</surname> <given-names>DG</given-names></name> <name><surname>Norman</surname> <given-names>PJ</given-names></name> <name><surname>Dandekar</surname> <given-names>R</given-names></name> <name><surname>Hollenbach</surname> <given-names>JA</given-names></name></person-group>. <article-title>Fluctuating and geographically specific selection characterize rapid evolution of the human KIR region</article-title>. <source>Front Immunol.</source> (<year>2019</year>) <volume>10</volume>:<fpage>989</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2019.00989</pub-id><pub-id pub-id-type="pmid">31156615</pub-id></citation></ref>
<ref id="B24">
<label>24.</label>
<citation citation-type="book"><person-group person-group-type="author"><name><surname>Gendzekhadze</surname> <given-names>K</given-names></name> <name><surname>Norman</surname> <given-names>PJ</given-names></name> <name><surname>Abi-Rached</surname> <given-names>L</given-names></name> <name><surname>Layrisse</surname> <given-names>Z</given-names></name> <name><surname>Parham</surname> <given-names>P</given-names></name></person-group>. <article-title>High KIR diversity in Amerindians is maintained using few gene-content haplotypes</article-title>. <source>Immunogenetics.</source> (<year>2006</year>) <volume>58</volume>(<issue>5&#x02013;6</issue>):<fpage>474</fpage>&#x02013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1007/s00251-006-0108-3</pub-id><pub-id pub-id-type="pmid">16738943</pub-id></citation></ref>
<ref id="B25">
<label>25.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nemat-Gorgani</surname> <given-names>N</given-names></name> <name><surname>Edinur</surname> <given-names>HA</given-names></name> <name><surname>Hollenbach</surname> <given-names>JA</given-names></name> <name><surname>Traherne</surname> <given-names>JA</given-names></name> <name><surname>Dunn</surname> <given-names>PPJ</given-names></name> <name><surname>Chambers</surname> <given-names>GK</given-names></name> <etal/></person-group>. <article-title>KIR diversity in M&#x00101;ori and polynesians: populations in which HLA-B is not a significant KIR ligand</article-title>. <source>Immunogenetics.</source> (<year>2014</year>) <volume>66</volume>:<fpage>597</fpage>&#x02013;<lpage>611</lpage>. <pub-id pub-id-type="doi">10.1007/s00251-014-0794-1</pub-id><pub-id pub-id-type="pmid">25139336</pub-id></citation></ref>
<ref id="B26">
<label>26.</label>
<citation citation-type="journal"><person-group person-group-type="author"><collab>The 1000Genomes Project Consortium</collab></person-group>. <article-title>A global reference for human genetic variation</article-title>. <source>Nature.</source> (<year>2015</year>) <volume>526</volume>:<fpage>68</fpage>&#x02013;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1038/nature15393</pub-id></citation></ref>
<ref id="B27">
<label>27.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gourraud</surname> <given-names>PA</given-names></name> <name><surname>Khankhanian</surname> <given-names>P</given-names></name> <name><surname>Cereb</surname> <given-names>N</given-names></name> <name><surname>Yang</surname> <given-names>SY</given-names></name> <name><surname>Feolo</surname> <given-names>M</given-names></name> <name><surname>Maiers</surname> <given-names>M</given-names></name> <etal/></person-group>. <article-title>HLA diversity in the 1000 genomes dataset</article-title>. <source>PLoS ONE.</source> (<year>2014</year>) <volume>9</volume>:<fpage>e97282</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0097282</pub-id><pub-id pub-id-type="pmid">24988075</pub-id></citation></ref>
<ref id="B28">
<label>28.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Apps</surname> <given-names>R</given-names></name> <name><surname>Qi</surname> <given-names>Y</given-names></name> <name><surname>Carlson</surname> <given-names>JM</given-names></name> <name><surname>Chen</surname> <given-names>H</given-names></name> <name><surname>Gao</surname> <given-names>X</given-names></name> <name><surname>Thomas</surname> <given-names>R</given-names></name> <etal/></person-group>. <article-title>Influence of HLA-C expression level on HIV control</article-title>. <source>Science.</source> (<year>2013</year>) <volume>340</volume>:<fpage>87</fpage>&#x02013;<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1126/science.1232685</pub-id><pub-id pub-id-type="pmid">23559252</pub-id></citation></ref>
<ref id="B29">
<label>29.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Norman</surname> <given-names>PJ</given-names></name> <name><surname>Hollenbach</surname> <given-names>JA</given-names></name> <name><surname>Nemat-Gorgani</surname> <given-names>N</given-names></name> <name><surname>Marin</surname> <given-names>WM</given-names></name> <name><surname>Norberg</surname> <given-names>SJ</given-names></name> <name><surname>Ashouri</surname> <given-names>E</given-names></name> <etal/></person-group>. <article-title>Defining KIR and HLA class I genotypes at highest resolution via high-throughput sequencing</article-title>. <source>Am J Hum Genet.</source> (<year>2016</year>) <volume>99</volume>:<fpage>375</fpage>&#x02013;<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2016.06.023</pub-id><pub-id pub-id-type="pmid">27486779</pub-id></citation></ref>
<ref id="B30">
<label>30.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Charoudeh</surname> <given-names>HN</given-names></name> <name><surname>Schmied</surname> <given-names>L</given-names></name> <name><surname>Gonzalez</surname> <given-names>A</given-names></name> <name><surname>Terszowski</surname> <given-names>G</given-names></name> <name><surname>Czaja</surname> <given-names>K</given-names></name> <name><surname>Schmitter</surname> <given-names>K</given-names></name> <etal/></person-group>. <article-title>Quantity of HLA-C surface expression and licensing of KIR2DL&#x0002B; natural killer cells</article-title>. <source>Immunogenetics.</source> (<year>2012</year>) <volume>64</volume>:<fpage>739</fpage>&#x02013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1007/s00251-012-0633-1</pub-id><pub-id pub-id-type="pmid">22772778</pub-id></citation></ref>
<ref id="B31">
<label>31.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname> <given-names>R</given-names></name> <name><surname>Apps</surname> <given-names>R</given-names></name> <name><surname>Qi</surname> <given-names>Y</given-names></name> <name><surname>Gao</surname> <given-names>X</given-names></name> <name><surname>Male</surname> <given-names>V</given-names></name> <name><surname>O&#x00027;Huigin</surname> <given-names>C</given-names></name> <etal/></person-group>. <article-title>HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C</article-title>. <source>Nat Genet.</source> (<year>2009</year>) <volume>41</volume>:<fpage>1290</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1038/ng.486</pub-id><pub-id pub-id-type="pmid">19935663</pub-id></citation></ref>
<ref id="B32">
<label>32.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kulkarni</surname> <given-names>S</given-names></name> <name><surname>Qi</surname> <given-names>Y</given-names></name> <name><surname>O&#x00027;hUigin</surname> <given-names>C</given-names></name> <name><surname>Pereyra</surname> <given-names>F</given-names></name> <name><surname>Ramsuran</surname> <given-names>V</given-names></name> <name><surname>McLaren</surname> <given-names>P</given-names></name> <etal/></person-group>. <article-title>Genetic interplay between HLA-C and MIR148A in HIV control and Crohn disease</article-title>. <source>Proc Natl Acad Sci USA.</source> (<year>2013</year>) <volume>110</volume>:<fpage>20705</fpage>&#x02013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1312237110</pub-id><pub-id pub-id-type="pmid">24248364</pub-id></citation></ref>
<ref id="B33">
<label>33.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>L</given-names></name> <name><surname>Leng</surname> <given-names>Q</given-names></name> <name><surname>Mixson</surname> <given-names>AJ</given-names></name></person-group>. <article-title>Alteration in the IL-2 signal peptide affects secretion of proteins <italic>in vitro</italic> and <italic>in vivo</italic></article-title>. <source>J Gene Med.</source> (<year>2005</year>) <volume>7</volume>:<fpage>354</fpage>&#x02013;<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1002/jgm.677</pub-id><pub-id pub-id-type="pmid">15619290</pub-id></citation></ref>
<ref id="B34">
<label>34.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wimley</surname> <given-names>WC</given-names></name> <name><surname>White</surname> <given-names>SH</given-names></name></person-group>. <article-title>Experimentally determined hydrophobicity scale for proteins at membrane interfaces</article-title>. <source>Nat Struct Biol.</source> (<year>1996</year>) <volume>3</volume>:<fpage>842</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1038/nsb1096-842</pub-id><pub-id pub-id-type="pmid">8836100</pub-id></citation></ref>
<ref id="B35">
<label>35.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dunphy</surname> <given-names>SE</given-names></name> <name><surname>Guinan</surname> <given-names>KJ</given-names></name> <name><surname>Chorcora</surname> <given-names>CN</given-names></name> <name><surname>Jayaraman</surname> <given-names>J</given-names></name> <name><surname>Traherne</surname> <given-names>JA</given-names></name> <name><surname>Trowsdale</surname> <given-names>J</given-names></name> <etal/></person-group>. <article-title>2DL1, 2DL2 and 2DL3 all contribute to KIR phenotype variability on human NK cells</article-title>. <source>Genes Immun</source>. (<year>2015</year>) <volume>16</volume>:<fpage>301</fpage>&#x02013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1038/gene.2015.15</pub-id><pub-id pub-id-type="pmid">25950617</pub-id></citation></ref>
<ref id="B36">
<label>36.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bari</surname> <given-names>R</given-names></name> <name><surname>Bell</surname> <given-names>T</given-names></name> <name><surname>Leung</surname> <given-names>WH</given-names></name> <name><surname>Vong</surname> <given-names>QP</given-names></name> <name><surname>Chan</surname> <given-names>WK</given-names></name> <name><surname>Das Gupta</surname> <given-names>N</given-names></name> <etal/></person-group>. <article-title>Significant functional heterogeneity among KIR2DL1 alleles and a pivotal role of arginine245</article-title>. <source>Blood.</source> (<year>2009</year>) <volume>114</volume>:<fpage>5182</fpage>&#x02013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2009-07-231977</pub-id><pub-id pub-id-type="pmid">19828694</pub-id></citation></ref>
<ref id="B37">
<label>37.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>B&#x000E9;ziat</surname> <given-names>V</given-names></name> <name><surname>Traherne</surname> <given-names>JA</given-names></name> <name><surname>Liu</surname> <given-names>LL</given-names></name> <name><surname>Jayaraman</surname> <given-names>J</given-names></name> <name><surname>Enqvist</surname> <given-names>M</given-names></name> <name><surname>Larsson</surname> <given-names>S</given-names></name> <etal/></person-group>. <article-title>Influence of KIR gene copy number on natural killer cell education</article-title>. <source>Blood.</source> (<year>2013</year>) <volume>121</volume>:<fpage>4703</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2012-10-461442</pub-id><pub-id pub-id-type="pmid">23637128</pub-id></citation></ref>
<ref id="B38">
<label>38.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Le Luduec</surname> <given-names>JB</given-names></name> <name><surname>Boudreau</surname> <given-names>JE</given-names></name> <name><surname>Freiberg</surname> <given-names>JC</given-names></name> <name><surname>Hsu</surname> <given-names>KC</given-names></name></person-group>. <article-title>Novel approach to cell surface discrimination between KIR2DL1 subtypes and KIR2DS1 identifies hierarchies in NK repertoire, education, and tolerance</article-title>. <source>Front Immunol.</source> (<year>2019</year>) <volume>10</volume>:<fpage>734</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2019.00734</pub-id><pub-id pub-id-type="pmid">31024561</pub-id></citation></ref>
<ref id="B39">
<label>39.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>He</surname> <given-names>Y</given-names></name> <name><surname>Tao</surname> <given-names>S</given-names></name> <name><surname>Ying</surname> <given-names>Y</given-names></name> <name><surname>He</surname> <given-names>J</given-names></name> <name><surname>Zhu</surname> <given-names>F</given-names></name> <name><surname>Lv</surname> <given-names>H</given-names></name></person-group>. <article-title>Allelic polymorphism, mRNA and antigen expression of KIR2DL1 in the Chinese Han population</article-title>. <source>Hum Immunol.</source> (<year>2014</year>) <volume>75</volume>:<fpage>245</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.humimm.2013.12.005</pub-id><pub-id pub-id-type="pmid">24374046</pub-id></citation></ref>
<ref id="B40">
<label>40.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yawata</surname> <given-names>M</given-names></name> <name><surname>Yawata</surname> <given-names>N</given-names></name> <name><surname>Draghi</surname> <given-names>M</given-names></name> <name><surname>Little</surname> <given-names>A-M</given-names></name> <name><surname>Partheniou</surname> <given-names>F</given-names></name> <name><surname>Parham</surname> <given-names>P</given-names></name></person-group>. <article-title>Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function</article-title>. <source>J Exp Med.</source> (<year>2006</year>) <volume>203</volume>:<fpage>633</fpage>&#x02013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20051884</pub-id><pub-id pub-id-type="pmid">16533882</pub-id></citation></ref>
<ref id="B41">
<label>41.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wright</surname> <given-names>PW</given-names></name> <name><surname>Li</surname> <given-names>H</given-names></name> <name><surname>Huehn</surname> <given-names>A</given-names></name> <name><surname>O&#x00027;Connor</surname> <given-names>GM</given-names></name> <name><surname>Cooley</surname> <given-names>S</given-names></name> <name><surname>Miller</surname> <given-names>JS</given-names></name> <etal/></person-group>. <article-title>Characterization of a weakly expressed KIR2DL1 variant reveals a novel upstream promoter that controls KIR expression</article-title>. <source>Genes Immun.</source> (<year>2014</year>) <volume>15</volume>:<fpage>440</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1038/gene.2014.34</pub-id><pub-id pub-id-type="pmid">24989671</pub-id></citation></ref>
<ref id="B42">
<label>42.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>H</given-names></name> <name><surname>Wright</surname> <given-names>PW</given-names></name> <name><surname>McCullen</surname> <given-names>M</given-names></name> <name><surname>Anderson</surname> <given-names>SK</given-names></name></person-group>. <article-title>Characterization of KIR intermediate promoters reveals four promoter types associated with distinct expression patterns of KIR subtypes</article-title>. <source>Genes Immun.</source> (<year>2016</year>) <volume>17</volume>:<fpage>66</fpage>&#x02013;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1038/gene.2015.56</pub-id><pub-id pub-id-type="pmid">26656451</pub-id></citation></ref>
<ref id="B43">
<label>43.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname> <given-names>J</given-names></name> <name><surname>Halliwell</surname> <given-names>JA</given-names></name> <name><surname>Hayhurst</surname> <given-names>JD</given-names></name> <name><surname>Flicek</surname> <given-names>P</given-names></name> <name><surname>Parham</surname> <given-names>P</given-names></name> <name><surname>Marsh</surname> <given-names>SGE</given-names></name></person-group>. <article-title>The IPD and IMGT/HLA database: Allele variant databases</article-title>. <source>Nucleic Acids Res.</source> (<year>2015</year>) <volume>43</volume>:<fpage>D423</fpage>&#x02013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gku1161</pub-id><pub-id pub-id-type="pmid">25414341</pub-id></citation></ref>
<ref id="B44">
<label>44.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nemat-Gorgani</surname> <given-names>N</given-names></name> <name><surname>Hilton</surname> <given-names>HG</given-names></name> <name><surname>Henn</surname> <given-names>BM</given-names></name> <name><surname>Lin</surname> <given-names>M</given-names></name> <name><surname>Gignoux</surname> <given-names>CR</given-names></name> <name><surname>Myrick</surname> <given-names>JW</given-names></name> <etal/></person-group>. <article-title>Different selected mechanisms attenuated the inhibitory interaction of KIR2DL1 with C2 &#x0002B; HLA-C in two indigenous human populations in Southern Africa</article-title>. <source>J Immunol.</source> (<year>2018</year>) <volume>200</volume>:<fpage>2640</fpage>&#x02013;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1701780</pub-id><pub-id pub-id-type="pmid">29549179</pub-id></citation></ref>
<ref id="B45">
<label>45.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>David</surname> <given-names>G</given-names></name> <name><surname>Djaoud</surname> <given-names>Z</given-names></name> <name><surname>Willem</surname> <given-names>C</given-names></name> <name><surname>Legrand</surname> <given-names>N</given-names></name> <name><surname>Rettman</surname> <given-names>P</given-names></name> <name><surname>Gagne</surname> <given-names>K</given-names></name> <etal/></person-group>. <article-title>Large spectrum of HLA-C recognition by killer Ig&#x02013;like receptor (KIR)2DL2 and KIR2DL3 and restricted C1 specificity of KIR2DS2: dominant impact of KIR2DL2/KIR2DS2 on KIR2D NK cell repertoire formation</article-title>. <source>J Immunol.</source> (<year>2013</year>) <volume>191</volume>:<fpage>4778</fpage>&#x02013;<lpage>88</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1301580</pub-id><pub-id pub-id-type="pmid">24078689</pub-id></citation></ref>
<ref id="B46">
<label>46.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Horowitz</surname> <given-names>A</given-names></name> <name><surname>Djaoud</surname> <given-names>Z</given-names></name> <name><surname>Nemat-Gorgani</surname> <given-names>N</given-names></name> <name><surname>Blokhuis</surname> <given-names>J</given-names></name> <name><surname>Hilton</surname> <given-names>HG</given-names></name> <name><surname>B&#x000E9;ziat</surname> <given-names>V</given-names></name> <etal/></person-group>. <article-title>Class I HLA haplotypes form two schools that educate NK cells in different ways</article-title>. <source>Sci Immunol.</source> (<year>2016</year>) <volume>1</volume>:<fpage>eaag1672</fpage>. <pub-id pub-id-type="doi">10.1126/sciimmunol.aag1672</pub-id><pub-id pub-id-type="pmid">27868107</pub-id></citation></ref>
<ref id="B47">
<label>47.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>H</given-names></name> <name><surname>Ivarsson</surname> <given-names>MA</given-names></name> <name><surname>Walker-Sperling</surname> <given-names>VE</given-names></name> <name><surname>Subleski</surname> <given-names>J</given-names></name> <name><surname>Johnson</surname> <given-names>JK</given-names></name> <name><surname>Wright</surname> <given-names>PW</given-names></name> <etal/></person-group>. <article-title>Identification of an elaborate NK-specific system regulating HLA-C expression</article-title>. <source>PLoS Genet.</source> (<year>2018</year>) <volume>14</volume>:<fpage>e1007163</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1007163</pub-id><pub-id pub-id-type="pmid">29329284</pub-id></citation></ref>
<ref id="B48">
<label>48.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Goodson-Gregg</surname> <given-names>FJ</given-names></name> <name><surname>Krepel</surname> <given-names>SA</given-names></name> <name><surname>Anderson</surname> <given-names>SK</given-names></name></person-group>. <article-title>Tuning of human NK cells by endogenous HLA-C expression</article-title>. <source>Immunogenetics.</source> (<year>2020</year>) <volume>72</volume>:<fpage>205</fpage>&#x02013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1007/s00251-020-01161-x</pub-id><pub-id pub-id-type="pmid">32219494</pub-id></citation></ref>
<ref id="B49">
<label>49.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moesta</surname> <given-names>AK</given-names></name> <name><surname>Norman</surname> <given-names>PJ</given-names></name> <name><surname>Yawata</surname> <given-names>M</given-names></name> <name><surname>Yawata</surname> <given-names>N</given-names></name> <name><surname>Gleimer</surname> <given-names>M</given-names></name> <name><surname>Parham</surname> <given-names>P</given-names></name></person-group>. <article-title>Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3</article-title>. <source>J Immunol.</source> (<year>2008</year>) <volume>180</volume>:<fpage>3969</fpage>&#x02013;<lpage>79</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.180.6.3969</pub-id><pub-id pub-id-type="pmid">18322206</pub-id></citation></ref>
<ref id="B50">
<label>50.</label>
<citation citation-type="book"><person-group person-group-type="author"><collab>IBGE</collab></person-group>. <source>Censo 2010.</source> <publisher-loc>Rio de Janeiro</publisher-loc>: <publisher-name>Atlas censo demografico</publisher-name> (<year>2013</year>).</citation></ref>
<ref id="B51">
<label>51.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Braun-Prado</surname> <given-names>K</given-names></name> <name><surname>Vieira Mion</surname> <given-names>AL</given-names></name> <name><surname>Farah Pereira</surname> <given-names>N</given-names></name> <name><surname>Culpi</surname> <given-names>L</given-names></name> <name><surname>Petzl-Erler</surname> <given-names>ML</given-names></name></person-group>. <article-title>HLA class I polymorphism, as characterised by PCR-SSOP, in a Brazilian exogamic population</article-title>. <source>Tissue Antigens.</source> (<year>2000</year>) <volume>56</volume>:<fpage>417</fpage>&#x02013;<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1034/j.1399-0039.2000.560504.x</pub-id><pub-id pub-id-type="pmid">11144289</pub-id></citation></ref>
<ref id="B52">
<label>52.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sanger</surname> <given-names>F</given-names></name> <name><surname>Nicklen</surname> <given-names>S</given-names></name> <name><surname>Coulson</surname> <given-names>AR</given-names></name></person-group>. <article-title>DNA sequencing with chain-terminating inhibitors</article-title>. <source>Proc Natl Acad Sci USA.</source> (<year>1977</year>) <volume>74</volume>:<fpage>5463</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.74.12.5463</pub-id><pub-id pub-id-type="pmid">271968</pub-id></citation></ref>
<ref id="B53">
<label>53.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hilton</surname> <given-names>HG</given-names></name> <name><surname>Norman</surname> <given-names>PJ</given-names></name> <name><surname>Nemat-Gorgani</surname> <given-names>N</given-names></name> <name><surname>Goyos</surname> <given-names>A</given-names></name> <name><surname>Hollenbach</surname> <given-names>JA</given-names></name> <name><surname>Henn</surname> <given-names>BM</given-names></name> <etal/></person-group>. <article-title>Loss and gain of natural killer cell receptor function in an African hunter-gatherer population</article-title>. <source>PLoS Genet.</source> (<year>2015</year>) <volume>11</volume>:<fpage>e1005439</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1005439</pub-id><pub-id pub-id-type="pmid">26292085</pub-id></citation></ref>
<ref id="B54">
<label>54.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Augusto</surname> <given-names>DG</given-names></name> <name><surname>Piovezan</surname> <given-names>BZ</given-names></name> <name><surname>Tsuneto</surname> <given-names>LT</given-names></name> <name><surname>Callegari-Jacques</surname> <given-names>SM</given-names></name> <name><surname>Petzl-Erler</surname> <given-names>ML</given-names></name></person-group>. <article-title>KIR gene content in Amerindians indicates influence of demographic factors</article-title>. <source>PLoS ONE</source>. (<year>2013</year>) <volume>8</volume>:<fpage>e56755</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0056755</pub-id><pub-id pub-id-type="pmid">23451080</pub-id></citation></ref>
<ref id="B55">
<label>55.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kulkarni</surname> <given-names>S</given-names></name> <name><surname>Martin</surname> <given-names>MP</given-names></name> <name><surname>Carrington</surname> <given-names>M</given-names></name></person-group>. <article-title>KIR genotyping by multiplex PCR-SSP</article-title>. <source>Methods Mol Biol.</source> (<year>2010</year>) <volume>612</volume>:<fpage>365</fpage>&#x02013;<lpage>375</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-60761-362-6_25</pub-id><pub-id pub-id-type="pmid">20033654</pub-id></citation></ref>
<ref id="B56">
<label>56.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bunce</surname> <given-names>M</given-names></name> <name><surname>O&#x00027;Neill</surname> <given-names>CM</given-names></name> <name><surname>Barnardo</surname> <given-names>MCNM</given-names></name> <name><surname>Krausa</surname> <given-names>P</given-names></name> <name><surname>Browning</surname> <given-names>MJ</given-names></name> <name><surname>Morris</surname> <given-names>PJ</given-names></name> <etal/></person-group>. <article-title>Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 &#x00026; DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP)</article-title>. <source>Tissue Antigens.</source> (<year>1995</year>) <volume>46</volume>:<fpage>355</fpage>&#x02013;<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1111/j.1399-0039.1995.tb03127.x</pub-id><pub-id pub-id-type="pmid">8838344</pub-id></citation></ref>
<ref id="B57">
<label>57.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vilches</surname> <given-names>C</given-names></name> <name><surname>Casta&#x000F1;o</surname> <given-names>J</given-names></name> <name><surname>G&#x000F3;mez-Lozano</surname> <given-names>N</given-names></name> <name><surname>Estefan&#x000ED;a</surname> <given-names>E</given-names></name></person-group>. <article-title>Facilitation of KIR genotyping by a PCR-SSP method that amplifies short DNA fragments</article-title>. <source>Tissue Antigens.</source> (<year>2007</year>) <volume>70</volume>:<fpage>415</fpage>&#x02013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1111/j.1399-0039.2007.00923.x</pub-id><pub-id pub-id-type="pmid">17854430</pub-id></citation></ref>
<ref id="B58">
<label>58.</label>
<citation citation-type="web"><person-group person-group-type="author"><name><surname>Gross</surname> <given-names>J</given-names></name> <name><surname>Ligges</surname> <given-names>U</given-names></name></person-group>. <source>Nortest: Tests for Normality.</source> (<year>2015</year>). Available online at: <ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/package=nortest">https://cran.r-project.org/package=nortest</ext-link> (accessed May 20, 2020).</citation></ref>
<ref id="B59">
<label>59.</label>
<citation citation-type="web"><person-group person-group-type="author"><collab>R Core Team</collab></person-group>. <source>R: A Language and Environment for Statistical Computing.</source> <publisher-loc>Vienna</publisher-loc>: <publisher-name>R Foundation for Statistical Computing</publisher-name> (<year>2019</year>). Available online at: <ext-link ext-link-type="uri" xlink:href="https://www.r-project.org/">https://www.r-project.org/</ext-link> (accessed July 06, 2020).</citation></ref>
<ref id="B60">
<label>60.</label>
<citation citation-type="web"><person-group person-group-type="author"><name><surname>Dinno</surname> <given-names>A</given-names></name></person-group>. <source>dunn. test: Dunn&#x00027;s test of multiple comparisons using rank sums.</source> (<year>2017</year>). Available online at: <ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/package=dunn.test">https://cran.r-project.org/package=dunn.test</ext-link> (accessed July 06, 2020).</citation></ref>
<ref id="B61">
<label>61.</label>
<citation citation-type="web"><person-group person-group-type="author"><name><surname>Jr</surname> <given-names>FEH</given-names></name> <name><surname>Dupont</surname> <given-names>C</given-names></name></person-group>. <source>Hmisc: Harrell Miscellaneous.</source> (<year>2019</year>). Available online at: <ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/package=Hmisc">https://cran.r-project.org/package=Hmisc</ext-link> (accessed July 06, 2020).</citation></ref>
<ref id="B62">
<label>62.</label>
<citation citation-type="web"><person-group person-group-type="author"><name><surname>Warnes</surname> <given-names>G</given-names></name> <name><surname>Gorjanc</surname> <given-names>G</given-names></name> <name><surname>Leisch</surname> <given-names>F</given-names></name> <name><surname>Man</surname> <given-names>M</given-names></name></person-group>. <source>Genetics: population genetics.</source> (<year>2019</year>). Available online at: <ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/package=genetics">https://cran.r-project.org/package=genetics</ext-link> (accessed May 20, 2020).</citation></ref>
<ref id="B63">
<label>63.</label>
<citation citation-type="book"><person-group person-group-type="author"><name><surname>Shin</surname> <given-names>J-H</given-names></name> <name><surname>Blay</surname> <given-names>S</given-names></name> <name><surname>Graham</surname> <given-names>J</given-names></name> <name><surname>McNeney</surname> <given-names>B</given-names></name></person-group>. <article-title>LDheatmap : an R function for graphical display of pairwise linkage disequilibria between single nucleotide polymorphisms</article-title>. <source>J Stat Softw.</source> (<year>2006</year>) <fpage>16</fpage>. <pub-id pub-id-type="doi">10.18637/jss.v016.c03</pub-id></citation></ref>
<ref id="B64">
<label>64.</label>
<citation citation-type="web"><person-group person-group-type="author"><name><surname>Eklund</surname> <given-names>A</given-names></name></person-group>. <source>Beeswarm: The Bee Swarm Plot, An Alternative To Stripchart</source>. R package version 0.2.0. (<year>2015</year>). Available online at: <ext-link ext-link-type="uri" xlink:href="http://cran.r-project.org/package=beeswarm">http://cran.r-project.org/package=beeswarm</ext-link> (accessed July 06, 2020).</citation></ref>
<ref id="B65">
<label>65.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sabeti</surname> <given-names>PC</given-names></name> <name><surname>Reich</surname> <given-names>DE</given-names></name> <name><surname>Higgins</surname> <given-names>JM</given-names></name> <name><surname>Levine</surname> <given-names>HZP</given-names></name> <name><surname>Richter</surname> <given-names>DJ</given-names></name> <name><surname>Schaffner</surname> <given-names>SF</given-names></name> <etal/></person-group>. <article-title>Detecting recent positive selection in the human genome from haplotype structure</article-title>. <source>Nature.</source> (<year>2002</year>) <volume>419</volume>:<fpage>832</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1038/nature01140</pub-id><pub-id pub-id-type="pmid">12397357</pub-id></citation></ref>
<ref id="B66">
<label>66.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gautier</surname> <given-names>M</given-names></name> <name><surname>Klassmann</surname> <given-names>A</given-names></name> <name><surname>Vitalis</surname> <given-names>R</given-names></name></person-group>. <article-title>rehh 2.0: a reimplementation of the R package rehh to detect positive selection from haplotype structure</article-title>. <source>Mol Ecol Resour.</source> (<year>2017</year>) <volume>17</volume>:<fpage>78</fpage>&#x02013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1111/1755-0998.12634</pub-id><pub-id pub-id-type="pmid">27863062</pub-id></citation></ref>
<ref id="B67">
<label>67.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sherry</surname> <given-names>ST</given-names></name> <name><surname>Ward</surname> <given-names>M</given-names></name> <name><surname>Kholodov</surname> <given-names>M</given-names></name> <name><surname>Baker</surname> <given-names>J</given-names></name> <name><surname>Phan</surname> <given-names>L</given-names></name> <name><surname>Smigielski</surname> <given-names>EM</given-names></name> <etal/></person-group>. <article-title>dbSNP : the NCBI database of genetic variation</article-title>. <source>Nucleic Acids Res.</source> (<year>2001</year>) <volume>29</volume>:<fpage>308</fpage>&#x02013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1093/nar/29.1.308</pub-id><pub-id pub-id-type="pmid">11125122</pub-id></citation></ref>
</ref-list>
<fn-group>
<fn fn-type="financial-disclosure"><p><bold>Funding.</bold> This work was supported by grants and scholarships from the Coordena&#x000E7;&#x000E3;o de Aperfei&#x000E7;oamento de Pessoal de N&#x000ED;vel Superior&#x02014;Brasil (CAPES)&#x02014;Finance Code 001, Conselho Nacional de Desenvolvimento Cient&#x000ED;fico e Tecnol&#x000F3;gico (CNPq), Funda&#x000E7;&#x000E3;o Arauc&#x000E1;ria and NIH grant U19NS095774.</p>
</fn>
</fn-group>
</back>
</article>